by admin | May 30, 2017 | News
Scottsdale, Ariz. May 30, 2017 Amendola Communications, an award-winning healthcare marketing and public relations agency, announced today that Bridge Therapeutics, Inc., has selected Amendola as its agency of record. Bridge Therapeutics, an innovative development-stage specialty pharmaceutical company, will be pursuing FDA and European Medicines Agency (EMA) approval of a patented (U.S. Patent #8410092) novel drug combination for the treatment of chronic pain in opioid-experienced patients.
Bridge selected Amendola after a rigorous agency review process. Amendola will provide a broad range of public relations and thought leadership services that promote Bridge Therapeutics as a pioneer and innovator in improving the lives of patients living with chronic pain through safer, more effective, and less addictive pain management.
Bridge Therapeutics investigational drug compound BT-205 is a unique combination of two synergistic chronic pain drugs the partial-agonist opioid buprenorphine and the NSAID meloxicam delivered in a state-of-the-art sublingual formulation. BT-205 is being developed to replace dangerous, full-agonist opioid-based drugs with a safer and more effective medication.
“We are excited that Amendola Communications will help us to bring our message about safer approaches to those struggling with chronic pain and addiction to the market,” said Alton Kelley, director of business development for Bridge Therapeutics. “Chronic pain affects more 100 million Americans today, which the Institutes of Medicine report is more than diabetes, heart disease and cancer combined. As we go through the FDA and EMA approval and commercialization process, we look forward to partnering with Amendola to help us educate the market about the benefits of replacing dangerous opioid-based drugs with a safer and more effective therapy for those struggling with chronic pain and addiction.”
BT-205 has the potential to be a new treatment option for healthcare providers around the world, and to offer patients an alternative chronic pain therapy. When dosed as a combination drug, buprenorphine and meloxicam have stronger pain relief effects, which allows the use of low dosage strengths of both and reduces the potential for negative side-effects.
Amendola Communications will provide targeted strategic public relations services, including media research, media relations, and the generation of top-tier awards and speaking opportunities. The agency will also be responsible for delivering a range of content demonstrating the thought leadership and expertise of Bridge Therapeutics key opinion leaders (KOLs), including bylined articles, poster presentations, press releases and other materials.
“Bridge Therapeutics offers an exciting and innovative approach to addressing the opioid addiction crisis facing our nation today,” said Jodi Amendola, CEO of Amendola Communications. “Addictive chronic pain drugs today kill more Americans than road crashes, and yet the massive chronic pain market in the United States still lacks a non-addictive pain medication. We look forward to promoting Bridge Therapeutics and its key opinion leaders as the company continues to go through its regulatory approval and commercialization process.”
About Amendola Communications
Amendola Communications is an award-winning national public relations, marketing communications, social media and content marketing firm. Named one of the best information technology (IT) PR firms in the nation four times by PRSourceCode, Amendola represents some of the best-known brands and groundbreaking startups in the healthcare and HIT industries. Amendola’s seasoned team of PR and marketing pros delivers strategic guidance and effective solutions to help organizations boost their reputation and drive market share. For more information about the PR industry’s “A Team,” visit www.acmarketingpr.com, and follow Amendola on Twitter and LinkedIn.
About Bridge Therapeutics
Bridge Therapeutics, based in Birmingham, Ala., is an innovative development-stage specialty pharmaceutical company pursuing U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) approvals of a patented (U.S. Patent #8410092) drug combination, BT-205, for the treatment of chronic pain in opioid-experienced patients. The investigational drug BT-205 is a unique combination of two synergistic chronic pain drugs the partial-agonist opioid buprenorphine and the NSAID meloxicam delivered in a state-of-the-art sublingual formulation. The dosing and delivery method will be a commercial advantage over the current alternatives. Bridge Therapeutics’ goal is to make the BT-205 compound and other investigational new drug candidates available to millions of patients in which addictive and potentially dangerous full-agonist opioids such as oxycodone and morphine are ineffective and/or unsatisfactory. The company is focused on improving the lives of patients living with chronic pain by developing new approaches to pain management that are safer, more effective, and less addictive. For more information, visit www.bridgetherapeutics.com.
Media Contact: Tara Stultz | 440.225.9595 | tstultz@acmarketingpr.com
by Administrator | May 17, 2017 | News
Interactive patient care leader selects award-winning PR agency to raise awareness in commercial and pediatric hospitals, government healthcare facilities and retail clinics.
SCOTTSDALE, Ariz. (May 17, 2017) Amendola Communications, a nationally recognized public relations, content creation and marketing firm specializing in health care and health information technology (HIT), announced today that it has been selected as the agency of record for Maryland-based GetWellNetwork®, Inc. The partnership began with public relations in late 2016 and expanded earlier this year to include integrated marketing communications to advance greater awareness about the work of GetWellNetwork, the industry’s only true provider of cross-continuum patient engagement solutions.
“Amendola has an award-winning team of public relations and marketing experts and former health IT journalists, all with a wealth of health care technology experience,” said Laura Bramschreiber, vice president of marketing for GetWellNetwork. “Their exclusive focus on health care was an important factor in our decision to partner with them. Amendola was the clear choice given their depth of industry knowledge and connections, as well as their reputation for outstanding client service.”
Bramschreiber continued, “With Amendola’s deep understanding of the market, coupled with their close relationships with key media organizations, the GetWellNetwork story of how we help patients and families take a more active role in their health care journey, is being shared with a wider audience than ever before.”
GetWellNetwork helps leading health care systems create connections with patients in any setting, deliver insights to clinicians in real time, and transform care through an evidence-based model for patient engagement. The company’s open technology integrates with electronic health records and IT applications to extend the value of existing investments and expand the possibilities of care.
“Now that almost every hospital has an electronic health record, it’s about optimizing and improving care delivery. Our team is passionate about driving a deeper understanding in the industry about how GetWellNetwork helps providers use data to create powerful connections to enhance the patient experience and improve health outcomes across the entire care continuum,” said Jodi Amendola, CEO of Amendola Communications. “We look forward to partnering with GetWellNetwork to educate the market about the art of the possible when it comes to delivering truly patient-centered care to every man, woman and child, not just in this country but around the world.”
About GetWellNetwork
GetWellNetwork, Inc. powers patient experience. Our solution, The Patient’s Platform, helps leading health care systems create connections with patients in any setting, deliver insights to clinicians in real time, and transform care through an evidence-based model for patient engagement. Our open technology integrates with electronic health record and IT applications to extend the value of existing investments and expand the possibilities of care. With more than 50 million patient interactions per year, we drive performance improvement, positive outcomes and patient loyalty. Learn more at www.getwellnetwork.com.
About Amendola Communications
Amendola Communications is an award-winning national public relations, marketing communications, social media and content marketing firm. Named one of the best information technology (IT) PR firms in the nation four times by PRSourceCode, Amendola represents some of the best-known brands and groundbreaking startups in the healthcare and HIT industries. Amendola’s seasoned team of PR and marketing pros delivers strategic guidance and effective solutions to help organizations boost their reputation and drive market share. For more information about the PR industry’s “A Team,” visit www.acmarketingpr.com, and follow Amendola on Twitter and LinkedIn.
Media Contact: Marcia Rhodes | mrhodes@acmarketingpr.com| 602.793.1561
by Tim Boivin | May 10, 2017 | Blog
When it comes to product launches, many companies hang their hat on making a big splash at the biggest trade show in their industry. And then they are disappointed.
For those targeting the healthcare IT market, that usually means HIMSS. For those targeting providers, the Medical Group Management Association (MGMA) show is often cited as a great launching pad.
For payers, it’s the Association of Health Insurance Plans (AHIP) Institute & Expo. For a life science/pharma audience, eyeforpharma Barcelona is a perennial favorite due to the heavy pharma presence in Europe.
But as Caterina Lui of PR Newswire points out on the Beyond PR blog, launching during a big show is not always ideal. And in another Beyond PR post, she provides excellent insights on whether your solution is even truly ready to launch.
One of the biggest drawbacks to launching at such large industry trade shows and conferences is the sheer number of companies who are planning to do likewise. This becomes an even more pronounced challenge if your company is launching a minor upgrade to its platform or app, or if your company is a newcomer or relative unknown in the market.
In both cases, a launch as much as a month or even two months before a trade show can help build momentum going into the show, instead of being crowded out by all the PR noise generated during the show. It allows you a greater opportunity to secure quality time with reporters whose conference schedules (covering educational sessions, filing stories, doing social media posts, etc.) are pretty crammed during the conference. It also allows you to brief analysts at the top firms ahead of the launch.
Here are some other best practices for trade show launches from my Amendola colleagues:
Lisa Chernikoff, Account Director In the best-case scenario for a product launch at a trade show, you can not only include results and ROI from a beta customer or pilot site in the press release, but also have that client available for an interview at the show (or before or after). Clients speaking about their experience with the product is much more beneficial than company execs talking about features and functionality.
Also, make sure that the new product info highlights not only what it is, but also why it really matters for the target audience. What are the larger implications for the market? How does it relate to industry trends and issues?
Chad Van Alstin, Content & Media Relations Manager As a former editor, I always found it challenging to cover product launches at trade shows without some kind of prior knowledge. Simply telling me a company was going to announce a product pretty much melded together with all the other launches after a while.
There has to be some kind of teaser or hook a spoiler that many companies are often hesitant to give away ahead of the show that is released to the media a week or two in advance. Otherwise, it all just becomes noise after a while, especially with a huge show like HIMSS. I think too many companies rely on the fact that editors will simply want to cover whatever it is the company is doing but in a market with so many new names added to a long list every year, that’s just never the case. You have to spoil things a little bit in order to drum up interest.
Amy Koehlmoos, Senior Account Director Leverage the power of social media – create a Twitter campaign around the product launch and use the show’s #hashtag to reach attendees. As with any campaign, frequency is key, but be sure to follow best practices and include plenty of non-promotional tweets to maintain an optimal content mix.
Rich media (images, videos and graphics) will help your tweets stand out above the noise, and don’t be afraid to get creative. People are much more likely to share a clever meme than a picture of a widget.
Stephanie Janard, Senior Writer — If you’re launching a new software solution, there’s no hard and fast rule that says you have to actually demo it. In this era of value-based care, why not stage a demo that
shows how life can be better as a result of using your newly launched software or app? Likewise, if you have a tangible, physical product to demo, make a real show of it preferably with a real-life example. If you can get champion customers on the act, all the better.
So there you have it from the A-Team experts (and PR Newswire). Should you bet it all on a trade show launch or not? It may be a crapshoot, but make sure you evaluate all your options both at the show and in other timeframes before committing your entire marketing budget to the effort. And please share your thoughts below on what you have seen that works well for a product launch either at, before or after a trade show.
by Administrator | May 9, 2017 | News
Agency insiders give tips to refresh and reenergize content marketing, tradeshows, social media and more
SCOTTSDALE, AZ., May 9, 2017 With more than half of the year still on the horizon, healthcare IT marketers and communicators are evaluating next steps to promote their companies. To jumpstart creative thinking, check out the following series of blog posts from Amendola Communications, a nationally recognized, award-winning healthcare and healthcare IT public relations and marketing agency.
“The Four P’s to Think Like a Marketer.” As marketers prepare their budgets, a few perennial questions emerge. Should more of the budget be allocated to content marketing or advertising? On trade shows or public relations? There is no shortage of options vying for the marketer’s dollar, but savvy marketers get that a balanced approach is better than risking most of their budget on a single strategy. With that, a terrific process exists to get the most results out of existing resources.
“Don’t Judge a Book by its Sales: Tips for Making Your Book a Relationship Magnet.” It’s a marketing vehicle tapped by relatively few companies, but a book can attract attention, credibility and leads galore. For executives seeking to establish their thought leadership or steer their way to media attention, penning an authoritative book could be the most direct path they take.
“Content Marketing: Remember to Ask “And Then?” A blog post or video that’s gone viral, a webinar that attracted lots of sign-ups”¦too often these are considered ideal end goals, when what they really should be are the starting points. Wise marketers plan ahead to make sure there’s always a next step in place to guide prospects to the sale.
“Tips for Social Media Success.” A social media presence is almost as important as a brick-and-mortar address, at least from a public relations and marketing standpoint. Yet for many companies, social media remains an enigma, especially with so many social media platforms to learn and navigate. And make no mistake, each does have its own set of best practices. The good news is there are universal guidelines to quickly become a competent practitioner of social media marketing and PR.
“HIMSS is Over, Now What?” Sure, HIMSS is several months in the rear view mirror. But there is still time left to leverage the investment made in the show, and act on the contacts and opportunities that were made to secure analyst coverage, bylines and more.
“The Press Release: Marketing’s Swiss Army Knife.” Just like the Swiss Army knife performs a multitude of functions, so too does the press release. In fact, this staple of public relations turns out to have a surprisingly versatile set of benefits for marketers, from SEO to lead gen. This is in addition to the good public relations and media attention that a strong press release can still generate.
“How to Make the News, Even When You’re Not the Headline.” Companies often hire PR agencies with the intent of getting front page coverage on USA Today or the Wall Street Journal or to star in an in-depth feature in a widely read trade publication. However, such a score rarely happens at the beginning of one’s PR effort; even Steve Jobs had to wait years to become a media darling. However, there are plenty of other ways to garner attention from the press that are of great value to any company.
Amendola’s blog posts cover all things public relations and marketing. A go-to source for communications professionals, the blog publishes on a weekly basis and features over a dozen subject matter experts in every aspect of publicizing and marketing healthcare technology companies.
About Amendola Communications
Amendola Communications is an award-winning national public relations, marketing communications, social media and content marketing firm. Named one of the best information technology (IT) PR firms in the nation four times by PRSourceCode, Amendola represents some of the best-known brands and groundbreaking startups in the healthcare and HIT industries. Amendola’s seasoned team of PR and marketing pros delivers strategic guidance and effective solutions to help organizations boost their reputation and drive market share. For more information about the PR industry’s “A Team,” visit www.acmarketingpr.com, and follow Amendola on Twitter and LinkedIn.
Media Contact:
Marcia Rhodes, Amendola Communications / mrhodes@acmarketingpr.com
by Julie Donnelly | Apr 26, 2017 | Blog
Dear Republicans, welcome to the Health Reform PR Fire Swamp (HRPRFS)! Like the Fire Swamp from the Princess Bride, the HRPRFS features several obstacles that did tremendous damage to the Affordable Care Act. As Republicans are hurtling forward with their ACA replacement bill, now called the American Health Care Act, it’s time to reflect on the Democrats failures. Here’s how Democrats fared against the Fire Swamp’s terrors, and how Republicans might avoid the same fate:
Flame Spurts: In the Princess Bride, flame spurts erupt seemingly unexpectedly in the Fire Swamp. But on closer inspection, it is discovered that a distinctive popping sound precedes each flame spurt, making them easier to avoid.
In the HRPRFS, it’s very clear that flame spurts erupt every time a blanket claim is made by a health care reform bill’s proponents. Case in point: former President Obama’s claim that “if you like your health care plan, you can keep it.” This statement will go down as one of the worst PR blunders of the Obama Administration. The reality was that 4 million people on the individual market had to switch plans, in many cases because their old plans did not meet the minimum creditable coverage standards imposed by the ACA. But it’s too late for explaining once the flame spurts have burned you ask Princess Buttercup.
Republicans seem to have learned something from the Democrats failure to avoid these flame spurts. HHS Secretary Tom Price, speaking earlier this month, stopped short of saying everyone would be able to keep their doctors with the ACA replacement bill, instead saying “Our goal is absolutely to make certain that individuals have the opportunity to select their physician.”
Rodents of Unusual Size: The Fire Swamp in the Princess Bride featured giant, gnarly rats with sharp teeth. The ACA, meanwhile, got hit with Premium Increases of Unusual Size. When it was reported last fall that premiums on the Arizona Health Exchange would grow by an average of 116 percent for a mid-level plan, those affected were outraged, and Republicans found a new rallying cry for their claims that “Obamacare is collapsing”.
Just one insurer remains in the market, down from eight health insurers last year, after the payers priced the products too low to adequately cover the costs of a sicker risk pool than had been predicted. It was reported at the time that just a small percentage of Arizona’s population buys their insurance on the ACA marketplace and that most of those receive subsidies to absorb those large increases. But it almost doesn’t matter.
After hearing those Premium Increases of Unusual Size, everything else just sounds like a dull hum. Those big numbers stick in the imagination of the public and explaining, again, is fruitless. Earlier this month, The New York Times tried again, publishing an interactive feature explaining that only 3 percent of Americans face ACA premium increases, because everyone else either has employer-sponsored health plans, which have faced modest increases in recent years, or they receive subsidies to cover large premium increases.
Republicans faced their own Rodent of Unusual Size when the Congressional Budget Office estimated that 24 million Americans would lose their health insurance under their proposed replacement bill. They attempted to defuse the anticipated RUS by discrediting the CBO ahead of time, explaining that the non-partisan agency had previously been wrong on ACA insured estimates. But that tactic mostly failed, and Republicans are busily amending the bill to try to reduce that 24 million uninsured number, while also appeasing conservatives who want to further limit Medicaid spending.
Lightning Sand: Another of the three terrors of the Princess Bride’s Fire Swamp is lightning sand, a drier and quicker form of quicksand that swallowed up Buttercup in an instant. When it comes to health reform PR, the lightning sand tends to suck in any positive PR, making it instantly disappear in the shadow of bad news.
The dominant story of the ACA over the past several months has been high prices and few choices for consumers. This narrative has drowned out more positive stories, such as how the ACA has enabled a large number of small business owners and entrepreneurs to access health coverage. The health reform PR lightning sand has also tended to bury encouraging ACA cost data. For instance, the federal government saved $7.4 billion in avoided payments to hospitals to cover the uninsured known as the uncompensated care pool in one year alone, 2014. More than two-thirds of these costs were avoided due to Medicaid expansion, a part of the ACA which is now in Republicans crosshairs.
Republicans are getting their first taste of the lightning sand, as the CBO estimated that their ACA replacement bill would save $337 billion, but it was quickly buried by the fact that the bill would increase the ranks of the uninsured by 24 million (See: RUSes, above).
**BONUS**
Bog of Eternal Stench: The pitfalls of health reform PR cannot adequately be contained by one 1980s fantasy film. So, I’ll offer Labyrinth’s Bog of Eternal Stench as an important cautionary tale for Republicans as they move their ACA replacement bill through Congress.
When it comes to PR, a botched launch stinks for a long, long time. The healthcare.gov debacle haunted the ACA for years. It severely hobbled the credibility of the Obama Administration’s health reform efforts, as well as causing actual harm for some consumers who were unable to sign up for new health plans in time. Reporters continued to write about it as late as 2016.
Republicans will necessarily have to overhaul or completely replace the federal exchange. State exchanges will also have to change dramatically to accommodate new plan designs, pricing structures and tax credits.
If Republicans decide to eliminate the exchanges, they will need to figure out how Americans will access these new plans instead. In any event, this upcoming transition is ripe for technical and operational challenges that are likely to have real human consequences. Republicans would do well to prepare the public ahead of time for road bumps, while maintaining realistic internal timelines.
Putting the Fire Swamp in the Rearview
In the Princess Bride, Buttercup and Westley manage to best all the Fire Swamp’s challenges and live happily ever after. Robin Wright has moved on from hapless Princess to shrewd First Lady, as Claire Underwood on House of Cards, with a very promising political future.
But that’s only in Hollywood. The only escape from the health reform PR Fire Swamp, it seems, is to hand off responsibility for crafting and executing the legislation to the other party. Democratic House Leader Nancy Pelosi has been clear, it’s the GOP’s Fire Swamp now. It’s Republicans turn to listen for the popping sounds before the flame spurts, and do their best to set Americans expectations about what this new incarnation of health reform will and won’t accomplish, and within what timeframe.
Page 18 of 30« First«...10...1617181920...30...»Last »